Drugs / Smile Care
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07241052 | Mar → Oct 2026 expected | dental caries | Anabio R&D | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Smile Care | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07241052 ↗ |
| Known as | LiveSpo Smile CARE | “LiveSpo® Smile CARE is manufactured as a Class-A medical device” NCT07241052 ↗ |
| Modality | Other / unclassified | “LiveSpo® Smile CARE, an oral-spray probiotic containing ≥ 1 × 10⁹ CFU/ mL Bacillus subtilis and Bacillus clausii” NCT07241052 ↗ |
| Route | Other | “LiveSpo® Smile CARE, an oral-spray probiotic containing ≥ 1 × 10⁹ CFU/ mL Bacillus subtilis and Bacillus clausii” NCT07241052 ↗ |